FDA Adverse Event Malfunction Summary report: N

I-STAT ACT KAOLIN CARTRIDGE

MDR report key: 24697519 · Received March 26, 2026

Report

Report Number
2245578-2026-00075
Event Type
Malfunction
Date Received
March 26, 2026
Date of Event
March 2, 2026
Report Date
May 13, 2026
Manufacturer
ABBOTT POINT OF CARE INC.
Product Code
JBP
PMA / PMN Number
K023582
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT # (B)(4) APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Description of Event or Problem · 0

ON (B)(6) 2026, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT ACT KAOLIN CARTRIDGES THAT YIELDED A DISCREPANT RESULTS ON A 77-YEAR-OLD CORONARY ARTERY DISEASE FEMALE PATIENT. THERE WAS NO ADDITIONAL PATIENT INFORMATION AVAILABLE. RETURN PRODUCT IS NOT AVAILABLE FOR INVESTIGATION. DATE: TESTED RESULTS(SEC): HEPARIN DOSE: HEPARIN TIME: (B)(6) 2026 , 6000, 08:12, (B)(6) 2026, 08:26, 158, (B)(6) 2026, 4000 , 08:27. (B)(6) 2026 , 08:41, 112, (B)(6) 2026 , 08:48 , 117, (B)(6) 2026 ,09:01, 153, (B)(6) 2026 , 09:02 , 163, (B)(6) 2026 , 09:25 , 307, AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON THE LIMITED INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. AN INVESTIGATION IS UNDERWAY. PER I-STAT SYSTEM MANUAL (ART: 714185-00Q), THE I-STAT KAOLIN ACTIVATED CLOTTING TIME (KAOLIN ACT) TEST IS AN IN VITRO DIAGNOSTIC TEST THAT USES FRESH, WHOLE BLOOD. AND IS USED TO MONITOR HIGH-DOSE HEPARIN ANTICOAGULATION FREQUENTLY ASSOCIATED WITH CARDIOVASCULAR SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
596483 I-STAT ACT KAOLIN CARTRIDGE ACT KAOLIN CARTRIDGE JBP ABBOTT POINT OF CARE INC. NA R25309

Patients

Seq Age Sex Outcome Treatment
1 77 YR Female